SAGINAW, Mich., Aug. 6, 2010 (GLOBE NEWSWIRE) -- Robertson Global Health Solutions Corporation (the "Company") (OTCBB:ASITD) announced today that it has formally completed its name change along with a 1 for 15 reverse stock split resulting in 11,543,346 shares of common stock currently issued and outstanding with 20,000,000 shares, par value $0.001, authorized. The Company also has 1,000,000 shares of preferred stock authorized, par value $0.001, with no preferred shares outstanding.
Filings with the Nevada Secretary of State and acceptance by FINRA of the name change and reverse split reflect the final steps connected with the May 28, 2010 reverse merger and recapitalization among ASI Technology Corporation (renamed Robertson Global Health Solutions Corporation) and NxOpinion, LLC ("NxOpinion"), a privately-owned health care technology licensing company headquartered in Saginaw, Michigan. As a result of the merger, the business of NxOpinion, is now owned by Robertson Health Services, Inc. ("RHS"), a wholly-owned subsidiary of the Company. For details of the merger and new management see the Company's regulatory filings at: www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=7951.
"With the previously announced name change and reverse stock split officially complete, we are now in a position to more clearly communicate our business and financial information," said Dr. Joel Robertson, Chairman and CEO. "We employ high-level intelligence oriented software to provide a comprehensive predictive diagnostic solution for global healthcare delivery. We look forward to communicating future business developments and progress to our stockholders and the investment community under the Robertson Health name."
About the Company -- The Company's seamless multi-platform software solution includes a powerful inference engine architecture branded as "NxOpinion(TM)", and a proprietary medical knowledge management system. The Company's clinical decision support platform mimics skilled clinical reasoning to determine the most possible and probable diagnosis and the best and latest treatment options given presenting symptoms, patient facts, health history, user skill level, geographical location, resources available and other available data. The Company offers the unique ability to deliver an accurate diagnosis, and an actionable response allowing optimized patient adherence, chronic disease monitoring, early detection of treatment failure, and referral to the appropriate level of care, pre-crisis intervention and real-time access to health information. The Company leverages this advantage in a global healthcare solution using technology to efficiently expand access to care worldwide while contributing to improved quality of care and reduced costs. For more information please visit the company's website at www.nxopinion.com/">www.nxopinion.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This document contains forward-looking statements relating to future performance and technology development that may affect future results of the company. Actual results could be affected or differ materially from those projected in the forward-looking statements as a result of risks and uncertainties, competition, general economic factors, and other factors identified and discussed in the Company's most recent filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from the Company's current expectations.